DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
MO-E115-IePD-F6-4 | 4D-THRIVE MRI for Internal Target Volume Estimation in Abdominal and Lung Radiation Therapy J Deng, T Aguilera, R Hannan, A Godley*, University of Texas Southwestern Medical Ctr, Dallas, Texas |
SU-E-202-1 | Uncertainty Analysis of Absorbed Dose Calculation in Targeted Radiotherapy Using a Bayesian Approach M BENSIALI1*, E Davesne1,2, E Chojnacki1, D Broggio1, S Lamart1, N Anizan3, S Leboulleux3,4, D Franck1, (1) Institute for Radiological Protection and Nuclear Safety (IRSN), Fontenay-aux-roses,FR, (2) INSTN, Gif-sur-Yvette, FR, (3) Gustave Roussy and Paris Saclay University,Villejuif, FR ,(4) Geneva University Hospitals, Geneva, SW |
SU-E-202-5 | Impact of Dosimetry Method On Organ and Tumor Absorbed Dose Estimates in Lutetium-177-DOTATATE Therapy of Neuroendocrine Tumors J Brosch-Lenz1*, A Rahmim1; 2; 3, C Uribe2; 3, (1) BC Cancer Research Institute, Vancouver, BC, CA, (2) University of British Columbia, Vancouver, BC, CA, (3) BC Cancer, Vancouver, BC |
SU-I400-BReP-F2-4 | CBCT Forecasting - A Convolution-LSTM Based Machine Learning Framework for Predicting “ahead-Of-Time” Patient Anatomy, Dose to Be Delivered, and Dose Trend in Head and Neck Radiotherapy A Santhanam1*, B Stiehl1, M Lauria1, R Savjani1, S Gros2,D Low1, (1) University of California, Los Angeles, Los Angeles, CA, (2) Loyola University Chicago, Chicago IL |
TH-B-202-4 | Personalized Dosimetry for Thyroid Metastatic Cancers: An Ancillary Study of the MERAIODE Clinical Trial (NCT 03244956) Using OEDIPE Software S Lamart1*, N Anizan2, A Legrand1, M Bensiali1, D Broggio1, S Leboulleux2,3, (1) Institut de Radioprotection et de Surete Nucleaire, Fontenay-aux-roses, FR, (2) Gustave Roussy et Universite Paris Saclay, Villejuif, FR, (3) Geneva University Hospitals, Geneva, SW |
TU-E-202-0 | ICRU Report On Dosimetry-Guided Radiopharmaceutical Therapy G Sgouros1*, K Sjogreen Gleisner2*, R Hobbs3*, Y Dewaraja4*, (1) Johns Hopkins Medical Institute, Ellicott City, MD, (2) Lund University, Lund, SE, (3) Johns Hopkins University, Baltimore, MD, (4) University of Michigan, Ann Arbor, MI |
TU-E-202-1 | Introduction to the ICRU Report On Dosimetry-Guided Radiopharmaceutcal Therapy G Sgouros1*, K Sjogreen Gleisner2*, R Hobbs3*, Y Dewaraja4*, (1) Johns Hopkins Medical Institute, Ellicott City, MD, (2) Lund University, Lund, SE, (3) Johns Hopkins University, Baltimore, MD, (4) University of Michigan, Ann Arbor, MI |
TU-E-202-2 | Nomenclature and Levels of Prescribing, Recording and Reporting G Sgouros1*, K Sjogreen Gleisner2*, R Hobbs3*, Y Dewaraja4*, (1) Johns Hopkins Medical Institute, Ellicott City, MD, (2) Lund University, Lund, SE, (3) Johns Hopkins University, Baltimore, MD, (4) University of Michigan, Ann Arbor, MI |
TU-E-202-3 | RBE and Bioeffect Modeling G Sgouros1*, K Sjogreen Gleisner2*, R Hobbs3*, Y Dewaraja4*, (1) Johns Hopkins Medical Institute, Ellicott City, MD, (2) Lund University, Lund, SE, (3) Johns Hopkins University, Baltimore, MD, (4) University of Michigan, Ann Arbor, MI |
TU-E-202-4 | Implementation Examples G Sgouros1*, K Sjogreen Gleisner2*, R Hobbs3*, Y Dewaraja4*, (1) Johns Hopkins Medical Institute, Ellicott City, MD, (2) Lund University, Lund, SE, (3) Johns Hopkins University, Baltimore, MD, (4) University of Michigan, Ann Arbor, MI |
TU-E-202-5 | Q & A G Sgouros1*, K Sjogreen Gleisner2*, R Hobbs3*, Y Dewaraja4*, (1) Johns Hopkins Medical Institute, Ellicott City, MD, (2) Lund University, Lund, SE, (3) Johns Hopkins University, Baltimore, MD, (4) University of Michigan, Ann Arbor, MI |
WE-F-206-6 | Radiobiological Effects of Ultra-High FLASH Dose Rate Using X-Rays Generated by the Small Animal Radiation Research Platform D Goia*, K Shoniyozov, A Velalopoulou, I Verginadis, M Kim, E Diffenderfer, L Dong, C Koumenis, University of Pennsylvania, Philadelphia, PA |